AroCell
0,54 SEK +4,85%2 investorer følger denne virksomhed
AroCell specializes in oncology and bacteriology. The company has a broad product portfolio, and develops, markets and sells blood and urine sample tests that are used by hospitals and clinics. The tests are intended to provide information for the detection of diseases such as urological cancers and typhoid fever. AroCell targets patient groups in different parts of the world. The head office is in Stockholm.
Omsætning
-
EBIT %
-
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
AROC
Daglig lav / høj pris
0,52 / 0,55
SEK
Markedsværdi
124,39 mio. SEK
Aktieomsætning
222,2 t SEK
Volumen
414 t
Seneste videoer
Finanskalender
Delårsrapport
21.08.2024
Delårsrapport
24.10.2024
Årsrapport
19.02.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Labbex Förvaltnings AB | 11,6 % | 11,6 % |
Avanza Pension | 9,4 % | 9,4 % |
Premium
This content is for our Premium customers only.
ViserAlle indholdstyper
Redeye: AroCell Q1 - Unrecognized and going well
AroCell AB (publ) Interim Report January 1st to March 31st, 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools